The H19 was upregulated in many tumors including esophageal squamous cell carcinoma [12], lung cancer [13], gastric cancer [14], and breast cancer [15], and H19 overexpression contributes to poor prognosis in these patients. This evidence concerns the gene H19 and breast cancer.